CardioNova Therapeutics is driven by a passion to help patients
We are the leading global structural heart innovation company, putting patients first in everything we do.
Learn More About Us
We are the leading global structural heart innovation company, putting patients first in everything we do.
Learn More About UsCardioNova Therapeutics develops breakthrough technologies to treat structural heart disease, offering minimally invasive treatment options to patients who are at risk from open-heart surgery. Our therapies are designed with the patient's quality of life at the center.
From transcatheter heart valves to advanced tissue technologies, we are committed to advancing the science of structural heart therapy through rigorous clinical evidence and relentless innovation.
Explore Our ProductsWhether you're a patient recently diagnosed with heart valve disease or a caregiver supporting a loved one, CardioNova Therapeutics has resources tailored for you.
Our Patient Support Center provides personalized guidance, financial assistance information, and connections to patient communities — because no one should face a heart condition alone.
Visit Patient Support Center
Continued growth driven by transcatheter heart valve therapies and expanded international presence.
Read More →
Landmark trial data confirms long-term safety and effectiveness of the NOVA transcatheter valve system.
Read More →
CardioNova recognized for pioneering RESILIA™-based tissue valves and minimally invasive procedures.
Read More →
